While the study of RBM20 targets is important to understand how mutations in its gene cause DCM, RBM20 regulation is where the therapeutic efforts should be focused to counteract disease development at its root rather than at its effects. This evidence concerns the gene RBM20 and familial dilated cardiomyopathy.